Eventide Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-770,691
| Closed | -$5.14M | – | 250 |
|
|
2025
Q1 | $5.14M | Hold |
770,691
| – | – | 0.1% | 144 |
|
|
2024
Q4 | $9.69M | Hold |
770,691
| – | – | 0.18% | 132 |
|
|
2024
Q3 | $14.2M | Hold |
770,691
| – | – | 0.25% | 104 |
|
|
2024
Q2 | $16.6M | Buy |
770,691
+279,959
| +57% | +$6.03M | 0.28% | 102 |
|
|
2024
Q1 | $13.2M | Hold |
490,732
| – | – | 0.21% | 109 |
|
|
2023
Q4 | $14.7M | Sell |
490,732
-407,268
| -45% | -$12.2M | 0.24% | 105 |
|
|
2023
Q3 | $18.4M | Hold |
898,000
| – | – | 0.33% | 90 |
|
|
2023
Q2 | $17.8M | Hold |
898,000
| – | – | 0.3% | 90 |
|
|
2023
Q1 | $15.4M | Buy |
898,000
+427,346
| +91% | +$7.32M | 0.28% | 98 |
|
|
2022
Q4 | $9.21M | Buy |
+470,654
| New | +$9.21M | 0.18% | 112 |
|
|
2020
Q4 | – | Sell |
-1,550,000
| Closed | -$35.4M | – | 161 |
|
|
2020
Q3 | $35.4M | Hold |
1,550,000
| – | – | 0.69% | 49 |
|
|
2020
Q2 | $32.4M | Buy |
1,550,000
+135,000
| +10% | +$2.83M | 0.71% | 53 |
|
|
2020
Q1 | $19.7M | Hold |
1,415,000
| – | – | 0.64% | 59 |
|
|
2019
Q4 | $32.2M | Hold |
1,415,000
| – | – | 0.91% | 43 |
|
|
2019
Q3 | $16.5M | Buy |
1,415,000
+420,686
| +42% | +$4.9M | 0.54% | 61 |
|
|
2019
Q2 | $14.9M | Buy |
994,314
+285,714
| +40% | +$4.29M | 0.45% | 70 |
|
|
2019
Q1 | $12.4M | Hold |
708,600
| – | – | 0.43% | 69 |
|
|
2018
Q4 | $10.5M | Buy |
708,600
+314,015
| +80% | +$4.65M | 0.46% | 67 |
|
|
2018
Q3 | $9.72M | Hold |
394,585
| – | – | 0.36% | 77 |
|
|
2018
Q2 | $7.75M | Hold |
394,585
| – | – | 0.32% | 82 |
|
|
2018
Q1 | $7.4M | Buy |
+394,585
| New | +$7.4M | 0.35% | 77 |
|